Commit To Buy Phathom Pharmaceuticals At $7.50, Earn 18.1% Annualized Using Options
April 09, 2024 at 11:32 AM EDT
Investors eyeing a purchase of Phathom Pharmaceuticals Inc (PHAT) shares, but cautious about paying the going market price of $11.67/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the December put at the $7.50 strike, which has a bid at the time of this writing of 95 cents..